Though the long-term mortality and morbidity results of patients who underwent endovascular treatment modalities are unknown, we recommend endovascular treatment to be administered in patients with high risk for open surgery and in centers with proper hybrid o-perating room conditions. In view of the tendency for less invasive methods for the treatment option in recent years, cardiovascular surgeons should review their positions on this. Assu-ming the 52% of the vascular interventions in 2012 will be performed via endovascular routes, the importance of this will be understood again. Cardiovascular surgery specialists are at a crossroads.
Aortic aneurysm is a condition in which the normal diameter in a localized site expands more than 50% (1.5 fold). Normal infrarenal aorta diameter is 21.4 mm in males and 18.7 mm in females. Abdominal aortic aneurysm (AAA) can be explained as the diameter of infrarenal aorta at a localized site permanently exceeding 3 cm. It is seen 5% of males over 50 years. This rate increases with the increasing average age and advancements in diagnostic modalities.
(1) AAA generally shows 0.5 cm expansion per year, and rupture develops as a result of its natural progress. Until rupture stage, mostly, asymptomatic course is observed. The risk of rupture is proportional to the diameter, and is increased in aneurysms over 5.5 cm. The cases should be treated under elective condition before rupture development.
(1,2,3)
Clinical Presentation
Approximately 75% of the cases have asymptomatic course. Symptoms are usually manifested with the growth of aneurysm sack, and rupture, embolization and thrombosis as a result of the pressure of this growth to surrounding tissues. Clinical symptoms can be examined in three groups:
1-Asymptomatic period: Includes approximately 75% of AAAs, and is detected by routine examination or testing.
2-Symptomatic period:
The most common symptom is abdominal and low-back pain. Abdominal pain may be continuous or intermittent, mild or severe. As a result of the pressure of aneurysm sack, nausea, vomiting, dyspepsia may occur. It may manifest itself with extremity ischemia due to distal embolization or aneurysm thrombosis.
3-Rupture Period: Severe abdominal and low back pain that has sudden onset and do not change with position indicates rapid growth or rupture. Approximately 20% of the cases in our country admits to hospital with rupture. Rupture patients are in shock, cold, sweaty and hypotensive. 
Diagnosis
Detection of aneurysms over 3.5 cm with physical examination is actually 15%.5 Currently, ultrasonography (USG) remains to be valueble for the initial diagnosis. Also, Contrast-enhanced Computerized Tomography (CT) which is a successful, relatively cheap, fast, and a reliable diagnostic modality in showing the rupture and aneurysm extension is a good option especially in patients who will undergo surgery. Contrast-enhanced CT should include thoracoabdominal sections. This way, accompanying thoracic aneurysms can also be detected. Angiography should be preferred generally in cases with accompanying peripheral arterial disease, renal artery stenosis or fistulization suspicion.
While mortality (30-day) in elective surgery cases is approximately 5%, it is around 50% in rupture patients. As this rate only includes the patients who reach the hospital, the real mortality rate of ruptured abdominal aneurysms is around 90%. Due to high mortality of the rupture, early diagnosis and elective treatment show the importance USG screening especially in patients over 60-65 years with AAA-related risk factors.
AAA related risk factors:
• Smoking
• Family history
• Hypertension
• COPD (Chronic obstructive pulmonary disease)
• Atherosclerotic disease (carotid stenosis, peripheral artery disease, etc.)
• Peripheral artery aneurysm (especially popliteal and iliac artery)
Treatment
Aneurysm diameter has a great importance in the treatment of AAAs. The risk of rupture development under 5 cm is reported to be 5%. (6) Annual risk of rupture that is increased proportionally with aneurysm diameter has been stated to be 0% for <4 cm, 1% for 4.5 cm, 11% for 5.5 cm and 26% for 6.5 cm. As is seen, there is a logarithmic relation between diameter increase and the risk of rupture. Many surgeons believe that surgery should be preferred in conditions in which the risk of rupture is more than the operative risk. One group advocates early surgical intervention (under 5 cm) and states that operative mortality is very low in young cases with low risk of surgery, that comorbidity and surgical risk may increase with the advancing age, and that for these reasons early surgical intervention is a good option.
In AAA with the diameter of 3-5 cm, in patients with no or less than 0.5 cm annual aneurysm diameter increase, follow-up is recommended.
• Patients whom recommended operative treatment (Surgery indications)
• Patients with an active live and AAA diameter of 5.5-5.9 cm
• All patients with the diameter of 6 cm and over
• Symptomatic patients with rapid diameter increase (>0.5cm in 6 months)
• There are two strategies as surgical treatment methods.
-Open surgery -Endovascular surgery (EVAR)
• While 30-day mortality of open surgery technique in elective AAA repair in 5%, and it has 15-30% rate of major complications. (7) Operative mortality may reach upto 50% in high risk patients. (8) Foreseeable major risks during classic surgical intervention are perioperative cardiac injury, and respiratory and renal failure.
At the present day, in addition to AAA screening, another factor that may reduce mortality rate and is a new treatment modality is endovascular aneurysm repair (EVAR) which is becoming widespread with fields of indication increasing day by day.
EVAR is applied since 1990s. In our country and our clinic, it became available in 2000s. It is a minimal invasive method as the physiological stress in the body and mortality rate is 3-fold less than open surgery, it is associated less morbidity and shorter anesthesia and intensive care period. 9 The efficacy of this method is still being investigated in clinical trials, and the trials in which the early-and medium-term results can be assessed were conducted (UK-EVAR, DREAM, EU-ROSTAR). Long-term results remain to be unknown. (10, 11, 12, 13, 14, 15) Eligibility for EVAR Treatment: In order for AAA cases to be eligible for endovascular procedure, they need to have vascular anatomic properties. Contrastenhance multislice CT and angiographic imaging are used for this. According to this:
• Aneurysm neck length should be > 15mm
• Diameter of the neck should be < 30 mm Grafts used in EVAR Treatment: As the initial grafts had aorto-aortoic tubular structure, there was a high rate of early complications. At the present day usually, branched (aorto-biiliac) or straight aortoiliac (aorto-uniiliac) grafts with stent are used. When uniiliac grafts are used, the contralateral iliac artery is occluded, thereby femoro-femoral bypass is performed. With the development of fenestrated stent grafts, stent extension at suprarenal level is also possible. Thus, it facilitates the treatment AAA with short proximal nect or extending to suprarenal level. Endovascular AAA repair can be applied under local, regional or general anesthesia. It is a technique which does not require major abdominal surgery. With this aspect, it is preferable in high-risk (serious cardiopulmonary disease or advanced age, accompanied morbid obesity and previous abdominal surgery) cases. However, after its feasibility is understood, it was started to be used in many patients with moderate and low risk patients with anatomical suitability. Its area of use gradually increases.16 However, there are problematic conditions associated with this treatment modality in-cluding anatomical nonconformity, endoleak, graft occlusion, aortic balloon dilatation. Due to great advancements in technology within the last 10 years, the tendency to EVAR as treatment modality in AAA cases has increased. In the upcoming years with more advanced devices, approximately 90% of AAA is thought to be treated with this method. Though the long-term mortality and morbidity results of patients who underwent endovascular treatment modalities are unknown, we recommend endovascular treatment to be administered in patients with high risk for open surgery and in centers with proper hybrid operating room conditions.
The advantages of Endovascular
In view of the tendency for less invasive methods for the treatment option in recent years, cardiovascular surgeons should review their positions on this. Assuming the 52% of the vascular interventions in 2012 will be performed via endovascular routes, the importance of this will be understood again. Cardiovascular surgery specialists are at a crossroads.
Also, new regulations should be made with rapid review of training programs of Cardiovascular surgery. Our centers should understand the importance of hybrid operation room, and make efforts to establish them.
